New Haven, CT’s HistoRx, which is developing tissue-based diagnostics, announced it has closed a $6 million Series B funding round. The deal was led by Brook Venture Partners, and joined by Navigator Technology Ventures, The Roche Venture Fund, Commons Capital, and Maven Capital.

Rebecca is Xconomy's co-founder. Follow @

• Share on Facebook
• Share on Twitter
• LinkedIn
• Email
• Reprints

Trending on Xconomy

• Review: Inside the House of Lies at Theranos
• Stoke Therapeutics Upsizes IPO, Raises $142M for Dravet Drug R&D
• Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer